Pei Ching Tsai

TumorNext-Lynch-MMR: a comprehensive next generation sequencing assay for the detection of germline and somatic mutations in genes associated with mismatch repair deficiency and Lynch syndrome

Phillip Gray, Pei Ching Tsai, Daniel Chen et al. · Oncotarget · 2018 · 29 citations · Full text

Medicine, Genetics, Molecular Genetics +17

DNA breakpoint assay reveals a majority of gross duplications occur in tandem reducing VUS classifications in breast cancer predisposition genes

Marcy E. Richardson, Hansook Kim Chong, Wenbo Mu et al. · Genetics in Medicine · 2018 · 29 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Decoding the evolutionary response to prostate cancer therapy by plasma genome sequencing

Naveen Ramesh, Emi Sei, Pei Ching Tsai et al. · Genome biology · 2020 · 14 citations · Full text

Life Sciences, Genetics, Oncology +17

TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy

Phillip Gray, Huy Gia Vuong, Pei Ching Tsai et al. · Oncotarget · 2016 · 10 citations · Full text

Medicine, Genetics, Oncology +17